A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity

被引:54
作者
Boules, M
Warrington, L
Fauq, A
McCormick, D
Richelson, E
机构
[1] Mayo Fdn Med Educ & Res, Neuropsychopharmacol Lab, Jacksonville, FL 32224 USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
[3] Mayo Clin Jacksonville, Mayo Chem Core Facil, Jacksonville, FL 32224 USA
[4] Mayo Clin, Mayo Prot Core Facil, Rochester, MN USA
关键词
neurotensin; cocaine; D-amphetamine; hyperactivity;
D O I
10.1016/S0014-2999(01)01197-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neurotensin is a tridecapeptide that exhibits selective anatomic and neurochemical interactions with dopaminergic systems. Since dopaminergic neurotransmission underlies many of the behavioral properties of psychostimulants, and since neurotensin has been implicated in modulating dopaminergic neurotransmitter systems, we tested the effect of our novel neurotensin analog, NT69L (N-methyl-Arg(8),L-Lys(9),L-neo-Trp(11),tert-Leu(12)]neurotensin-(8-13)), on hyperactivity caused by cocaine and D-amphetamine. Previously, we showed that NT69L reduces body temperature, blocks apomorphine-induced climbing, and haloperidol-induced catalepsy. In this study, NT69L blocked the hyperactivity induced by both cocaine and D-amphetamine administered at three different doses each, when this peptide was injected intraperitoneally. These results provide further evidence for the involvement of the neurotensin system in some of the behavioral properties of psychostimulants and suggest that NT69L may find clinical application in patients who abuse this class of compounds. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:73 / 76
页数:4
相关论文
共 24 条
  • [1] Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine
    Betancur, C
    Cabrera, R
    de Kloet, R
    Pélaprat, D
    Rostène, W
    [J]. NEUROPSYCHOPHARMACOLOGY, 1998, 19 (04) : 322 - 332
  • [2] A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents
    Boules, M
    Cusack, B
    Zhao, LH
    Fauq, A
    McCormick, DJ
    Richelson, E
    [J]. BRAIN RESEARCH, 2000, 865 (01) : 35 - 44
  • [3] CHRONIC CONTINUOUS OR INTERMITTENT INFUSION OF COCAINE DIFFERENTIALLY ALTER THE CONCENTRATION OF NEUROTENSIN-LIKE IMMUNOREACTIVITY IN SPECIFIC RAT-BRAIN REGIONS
    CAIN, ST
    GRIFF, D
    JOYNER, CM
    ELLINWOOD, EH
    NEMEROFF, CB
    [J]. NEUROPSYCHOPHARMACOLOGY, 1993, 8 (03) : 259 - 265
  • [4] The neurotensin receptor antagonist SR 48692, decreases extracellular striatal GABA in rats
    Chapman, MA
    See, RE
    [J]. BRAIN RESEARCH, 1996, 729 (01) : 124 - 126
  • [5] Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol
    Cusack, B
    Boules, M
    Tyler, BM
    Fauq, A
    McCormick, DJ
    Richelson, E
    [J]. BRAIN RESEARCH, 2000, 856 (1-2) : 48 - 54
  • [6] ERVIN GN, 1981, NATURE, V291, P73, DOI 10.1038/291073a0
  • [7] Ferraro L, 1998, J NEUROSCI, V18, P6977
  • [8] RESPONSE BY THE NEUROTENSIN SYSTEMS OF THE BASAL GANGLIA TO COCAINE TREATMENT
    HANSON, GR
    SMILEY, P
    JOHNSON, M
    LETTER, A
    BUSH, L
    GIBB, JW
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 160 (01) : 23 - 30
  • [9] JACOBS S, 1991, NEW BIOL, V3, P110
  • [10] JOHANSON CE, 1989, PHARMACOL REV, V41, P3